Healthcare - Biotechnology - NASDAQ - US
$ 2.84
-5.8 %
$ 326 M
Market Cap
-3.05
P/E
INCOME STATEMENT
5.72 M
REVENUE
-116 M
OPERATING INCOME
-111 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Absci Corporation
| Revenue | 5.72 M |
| Cost Of Revenue | 47.6 M |
| Gross Profit | -41.8 M |
| Operating Expenses | 73.7 M |
| Operating Income | -116 M |
| Other Expenses | -4.95 M |
| Net Income | -111 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 5.7 | 5.7 | 4.8 | 4.8 | 2.1 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 47.6 | 13.0 | 6.7 | 11.4 | 4.3 |
| Gross Profit | (41.8) | (7.3) | (1.9) | (6.7) | (2.3) |
| OPERATING INCOME | |||||
| Operating Expenses | 73.7 | 112.5 | 80.0 | 18.1 | 8.3 |
| Selling, General and Administrative Expenses | 37.8 | 40.6 | 28.8 | 5.5 | 3.5 |
| Research and Development Expenses | 48.1 | 58.9 | 44.6 | 11.4 | 4.3 |
| Operating Income | (115.5) | (106.8) | (75.2) | (13.3) | (6.3) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 1.0 | 1.0 | 3.4 | 0.6 | 0.3 |
| Total Other Income | 5.0 | 1.4 | (34.6) | (1.1) | (0.3) |
| Pre-Tax Income | (110.5) | (105.4) | (109.9) | (14.4) | (6.6) |
| NET INCOME | |||||
| Tax Provision | 100 K | (0.5) | (8.9) | 0.2 | 0.2 |
| Net Income | (110.6) | (104.9) | (101.0) | (14.6) | (6.8) |
| EPS | 1.2 | 1.15 | 1.09 | 0.16 | 0.0737 |